• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过中空金纳米壳递送来提高 BCL-2 表型转换的体内靶向性。

Improved in vivo targeting of BCL-2 phenotypic conversion through hollow gold nanoshell delivery.

机构信息

Department of Chemistry and Biochemistry, University of California, Santa Barbara, CA, USA.

Department of Environmental and Molecular Toxicology, Oregon State University, Corvallis, OR, USA.

出版信息

Apoptosis. 2019 Jun;24(5-6):529-537. doi: 10.1007/s10495-019-01531-1.

DOI:10.1007/s10495-019-01531-1
PMID:30879165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8918063/
Abstract

Although new cancer therapeutics are discovered at a rapid pace, lack of effective means of delivery and cancer chemoresistance thwart many of the promising therapeutics. We demonstrate a method that confronts both of these issues with the light-activated delivery of a Bcl-2 functional converting peptide, NuBCP-9, using hollow gold nanoshells. This approach has shown not only to increase the efficacy of the peptide 30-fold in vitro but also has shown to reduce paclitaxel resistant H460 lung xenograft tumor growth by 56.4%.

摘要

尽管新的癌症治疗方法正在快速被发现,但缺乏有效的传递手段和癌症化疗耐药性使许多有前途的治疗方法受阻。我们展示了一种使用中空金纳米壳用光激活传递 Bcl-2 功能转化肽 NuBCP-9 的方法来应对这两个问题。这种方法不仅显示出在体外使肽的功效提高了 30 倍,而且还显示出将紫杉醇耐药的 H460 肺异种移植肿瘤生长减少了 56.4%。

相似文献

1
Improved in vivo targeting of BCL-2 phenotypic conversion through hollow gold nanoshell delivery.通过中空金纳米壳递送来提高 BCL-2 表型转换的体内靶向性。
Apoptosis. 2019 Jun;24(5-6):529-537. doi: 10.1007/s10495-019-01531-1.
2
Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells.大孔硅纳米颗粒用于递送 Bcl2 功能转换肽以治疗多药耐药癌细胞。
J Colloid Interface Sci. 2018 Oct 1;527:141-150. doi: 10.1016/j.jcis.2018.05.033. Epub 2018 May 15.
3
Cancer-targeted and intracellular delivery of Bcl-2-converting peptide with functional macroporous silica nanoparticles for biosafe treatment.用具有功能化大孔硅纳米粒子的 Bcl-2 转化肽进行肿瘤靶向和细胞内递送来进行生物安全治疗。
Mater Sci Eng C Mater Biol Appl. 2020 Mar;108:110386. doi: 10.1016/j.msec.2019.110386. Epub 2019 Nov 5.
4
In situ fabrication of mesoporous silica-coated silver-gold hollow nanoshell for remotely controllable chemo-photothermal therapy via phase-change molecule as gatekeepers.通过相变分子作为守门员,在原位制备介孔硅包覆的银金中空纳米壳,用于远程可控的化学-光热治疗。
Int J Pharm. 2018 Sep 5;548(1):92-103. doi: 10.1016/j.ijpharm.2018.06.056. Epub 2018 Jun 27.
5
Target-specific near-IR induced drug release and photothermal therapy with accumulated Au/Ag hollow nanoshells on pulmonary cancer cell membranes.基于肺癌细胞膜上 Au/Ag 中空纳米壳的靶向近红外光诱导药物释放和光热治疗。
Biomaterials. 2015 Mar;45:81-92. doi: 10.1016/j.biomaterials.2014.12.036. Epub 2015 Jan 16.
6
PEGylated thermosensitive lipid-coated hollow gold nanoshells for effective combinational chemo-photothermal therapy of pancreatic cancer.聚乙二醇化的温敏脂质包覆空心金纳米壳用于胰腺癌的有效联合化疗-光热治疗。
Colloids Surf B Biointerfaces. 2017 Dec 1;160:73-83. doi: 10.1016/j.colsurfb.2017.09.010. Epub 2017 Sep 8.
7
Apoferritin nanocages with Au nanoshell coating as drug carrier for multistimuli-responsive drug release.载金纳米壳的脱铁铁蛋白纳米笼作为多刺激响应性药物载体用于药物释放。
Mater Sci Eng C Mater Biol Appl. 2019 Feb 1;95:11-18. doi: 10.1016/j.msec.2018.10.060. Epub 2018 Oct 16.
8
A short Nur77-derived peptide converts Bcl-2 from a protector to a killer.一段源自Nur77的短肽将Bcl-2从保护者转变为杀手。
Cancer Cell. 2008 Oct 7;14(4):285-98. doi: 10.1016/j.ccr.2008.09.002.
9
Novel polymeric nanoparticles for intracellular delivery of peptide Cargos: antitumor efficacy of the BCL-2 conversion peptide NuBCP-9.用于肽类 Cargo 细胞内递送的新型聚合物纳米颗粒:BCL-2 转化肽 NuBCP-9 的抗肿瘤疗效
Cancer Res. 2014 Jun 15;74(12):3271-81. doi: 10.1158/0008-5472.CAN-13-2015. Epub 2014 Apr 16.
10
PTD modified paclitaxel anti-resistant liposomes for treatment of drug-resistant non-small cell lung cancer.PTD 修饰的紫杉醇抗耐药脂质体治疗耐药性非小细胞肺癌。
J Liposome Res. 2018 Sep;28(3):236-248. doi: 10.1080/08982104.2017.1327542. Epub 2017 May 24.

引用本文的文献

1
Small Molecule Functional Converter of B-Cell Lymphoma-2 (Bcl-2) Suppresses Breast Cancer Lung Metastasis.B细胞淋巴瘤-2(Bcl-2)小分子功能转化剂抑制乳腺癌肺转移。
ACS Pharmacol Transl Sci. 2024 May 1;7(5):1302-1309. doi: 10.1021/acsptsci.3c00360. eCollection 2024 May 10.
2
Identification and Characterization of a Small Molecule Bcl-2 Functional Converter.鉴定和表征一种小分子 Bcl-2 功能转化器。
Cancer Res Commun. 2024 Mar 4;4(3):634-644. doi: 10.1158/2767-9764.CRC-22-0526.
3
Zebrafish in Lung Cancer Research.斑马鱼在肺癌研究中的应用

本文引用的文献

1
Corrigendum to 'Concomitant delivery of paclitaxel and NuBCP-9 peptide for synergistic enhancement of cancer therapy' NANO 14 (2018) 1301-1313.《紫杉醇与NuBCP-9肽联合递送协同增强癌症治疗》勘误,发表于《纳米》2018年第14卷,第1301 - 1313页。
Nanomedicine. 2018 Oct;14(7):2129. doi: 10.1016/j.nano.2018.07.001. Epub 2018 Jul 24.
2
Induction of apoptosis and suppression of tumor growth by Nur77-derived Bcl-2 converting peptide in chemoresistant lung cancer cells.Nur77衍生的Bcl-2转化肽在化疗耐药肺癌细胞中诱导凋亡并抑制肿瘤生长
Oncotarget. 2018 May 25;9(40):26072-26085. doi: 10.18632/oncotarget.25437.
3
Acquired resistance to venetoclax (ABT-199) in t(14;18) positive lymphoma cells.
Cancers (Basel). 2023 Sep 26;15(19):4721. doi: 10.3390/cancers15194721.
4
11-Cl-BBQ, a select modulator of AhR-regulated transcription, suppresses lung cancer cell growth via activation of p53 and p27.11-Cl-BBQ,一种 AhR 调节转录的选择性调节剂,通过激活 p53 和 p27 抑制肺癌细胞生长。
FEBS J. 2023 Apr;290(8):2064-2084. doi: 10.1111/febs.16683. Epub 2022 Dec 22.
5
The Zebrafish Xenograft Models for Investigating Cancer and Cancer Therapeutics.用于研究癌症和癌症治疗的斑马鱼异种移植模型。
Biology (Basel). 2021 Mar 24;10(4):252. doi: 10.3390/biology10040252.
6
VIPER: Improved Live Cell Intracellular Protein Tracking.VIPER:改良活细胞内蛋白追踪技术。
ACS Appl Mater Interfaces. 2019 Oct 9;11(40):36383-36390. doi: 10.1021/acsami.9b12679. Epub 2019 Oct 1.
t(14;18) 阳性淋巴瘤细胞对维奈托克(ABT-199)的获得性耐药
Oncotarget. 2016 Oct 25;7(43):70000-70010. doi: 10.18632/oncotarget.12132.
4
Zebrafish: A complete animal model to enumerate the nanoparticle toxicity.斑马鱼:一种用于评估纳米颗粒毒性的完整动物模型。
J Nanobiotechnology. 2016 Aug 20;14(1):65. doi: 10.1186/s12951-016-0217-6.
5
Intracellular delivery of peptide cargos using polyhydroxybutyrate based biodegradable nanoparticles: Studies on antitumor efficacy of BCL-2 converting peptide, NuBCP-9.使用基于聚羟基丁酸酯的可生物降解纳米颗粒进行肽类货物的细胞内递送:BCL-2转化肽NuBCP-9的抗肿瘤功效研究
Int J Pharm. 2016 Sep 25;511(2):876-89. doi: 10.1016/j.ijpharm.2016.07.077. Epub 2016 Aug 1.
6
Developing a Novel Embryo-Larval Zebrafish Xenograft Assay to Prioritize Human Glioblastoma Therapeutics.开发一种新型胚胎-幼虫斑马鱼异种移植试验以优化人胶质母细胞瘤治疗方法。
Zebrafish. 2016 Aug;13(4):317-29. doi: 10.1089/zeb.2015.1170. Epub 2016 May 9.
7
Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.根据激素受体状态或辅助内分泌治疗,Bcl-2在乳腺癌中的临床重要性差异。
BMC Cancer. 2015 Oct 15;15:698. doi: 10.1186/s12885-015-1686-y.
8
Quinoxaline-Based Polymer Dots with Ultrabright Red to Near-Infrared Fluorescence for In Vivo Biological Imaging.基于喹喔啉的聚合物点具有超亮的红色到近红外荧光,可用于活体生物成像。
J Am Chem Soc. 2015 Aug 19;137(32):10420-9. doi: 10.1021/jacs.5b06710. Epub 2015 Aug 10.
9
Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy.雌激素受体(ER)信号上调作为抗HER2治疗的HER2阳性乳腺肿瘤细胞存活的一种适应性机制
Clin Cancer Res. 2015 Sep 1;21(17):3995-4003. doi: 10.1158/1078-0432.CCR-14-2728. Epub 2015 May 26.
10
BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy.BCL2是接受基于蒽环类药物辅助化疗的基底样三阴性乳腺癌预后的独立预测指标。
Tumour Biol. 2015 Jun;36(6):4243-52. doi: 10.1007/s13277-015-3061-7. Epub 2015 Jan 24.